We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lead Plaintiffs Seek Class Certification In Securities Suit Against Drug Maker

(July 14, 2017, 1:31 PM EDT) -- BOSTON — A federal judge should grant a motion for class certification filed by lead plaintiffs in a securities class action lawsuit against a biopharmaceutical company and certain of its executive officers because the lead plaintiffs have satisfied all statutory requirements for certification, the lead plaintiffs argue in a motion for class certification filed June 29 in Massachusetts federal court (In re AVEO Pharmaceuticals Inc. Securities Litigation, No. 13-11157, D. Mass.).

(Motion for class certification available.  Document #57-170717-503B.)

Lead plaintiffs Robert Levine and William Windham filed...
To view the full article, register now.